Problem

Image: A transmission electron micrograph shows Ebola virus particles in this undated handout image released by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fredrick, Maryland. Credit: Reuters/USAMRIID/Handout

reuters.com - November 5th 2014 - Julie Steenhuysen

Scientists across the United States say they cannot obtain samples of Ebola, complicating efforts to understand how the virus is mutating and develop new drugs, vaccines and diagnostics.

The problems reflect growing caution by regulators and transport companies about handling Ebola as well as the limited resources of West African countries which are struggling to help thousands of infected citizens.

ABC NEWS                                       Nov. 3, 2014
By LIZ NEPORENT via Good Morning America

West Africans fortunate to survive Ebola may go on to develop what's being called "post-Ebola syndrome," characterized by vision loss and long-term poor health, a doctor told a World health Organization.

People stand in the "red zone" where they are being treated for Ebola at the Bong County Ebola Treatment Unit in Monrovia, Liberia, Oct. 28, 2014.

Overview of what still needs to be learned about the Ebola virus

Research studies have suggested at least three potential paths through which the Ebola virus can invade tissues. Credit Photograph by the C.D.C. via Getty Images

THE NEW YORKER                                      Nov. 1, 2014

By Jerome Groopman

...there are still serious gaps in what we know about the biology of Ebola, and that ignorance inhibits us from preventing future outbreaks and reducing death rates that still exceed seventy per cent. We don’t know enough about the biology of Ebola to bring the outbreak under full control, or to neutralize the virus once the outbreak is contained. Between on-the-ground efforts and advances in science, we need a balanced approach.

Read complete article

THE GUARDIAN                                                                                Oct. 28, 2014
By Sarah Boseley

West Africa, now in the throes of a calamitous Ebola epidemic, missed out on significant health investment over the past decade or more because it had low rates of HIV, a detailed survey of the changing health of Africa and Asia reveals.

The US ambassador to the UN, Samantha Power (centre), visits an ebola emergency response centre in Freetown, Sierra Leone. Healthcare in west Africa now has the world’s attention. Photograph: Reuters

A major project called Indepth, which has looked at the causes of death of more than 110,000 people in 13 countries shows that health improved generally in those given substantial international aid to try to turn around the HIV and Aids epidemic. But west Africa, with severe poverty and low healthcare standards but relatively little HIV, did not benefit.